Ruggiero, R.; Donniacuo, M.; Mascolo, A.; Gaio, M.; Cappetta, D.; Rafaniello, C.; Docimo, G.; Riccardi, C.; Izzo, I.; Ruggiero, D.;
et al. COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database. Biomedicines 2023, 11, 1584.
https://doi.org/10.3390/biomedicines11061584
AMA Style
Ruggiero R, Donniacuo M, Mascolo A, Gaio M, Cappetta D, Rafaniello C, Docimo G, Riccardi C, Izzo I, Ruggiero D,
et al. COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database. Biomedicines. 2023; 11(6):1584.
https://doi.org/10.3390/biomedicines11061584
Chicago/Turabian Style
Ruggiero, Rosanna, Maria Donniacuo, Annamaria Mascolo, Mario Gaio, Donato Cappetta, Concetta Rafaniello, Giovanni Docimo, Consiglia Riccardi, Imma Izzo, Donatella Ruggiero,
and et al. 2023. "COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database" Biomedicines 11, no. 6: 1584.
https://doi.org/10.3390/biomedicines11061584
APA Style
Ruggiero, R., Donniacuo, M., Mascolo, A., Gaio, M., Cappetta, D., Rafaniello, C., Docimo, G., Riccardi, C., Izzo, I., Ruggiero, D., Paolisso, G., Rossi, F., De Angelis, A., & Capuano, A.
(2023). COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database. Biomedicines, 11(6), 1584.
https://doi.org/10.3390/biomedicines11061584
